Compare CGEN & FC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CGEN | FC |
|---|---|---|
| Founded | 1993 | 1983 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 270.4M | 262.2M |
| IPO Year | 2001 | 1994 |
| Metric | CGEN | FC |
|---|---|---|
| Price | $2.85 | $21.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $5.00 | ★ $26.00 |
| AVG Volume (30 Days) | ★ 518.7K | 69.6K |
| Earning Date | 05-18-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $267,067,000.00 |
| Revenue This Year | N/A | $3.15 |
| Revenue Next Year | $75.09 | $4.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.29 | $11.16 |
| 52 Week High | $3.24 | $24.70 |
| Indicator | CGEN | FC |
|---|---|---|
| Relative Strength Index (RSI) | 57.92 | 51.02 |
| Support Level | $1.46 | $20.64 |
| Resistance Level | $3.24 | $21.41 |
| Average True Range (ATR) | 0.16 | 1.09 |
| MACD | -0.02 | -0.32 |
| Stochastic Oscillator | 44.60 | 26.58 |
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
Franklin Covey Co is a company focused on organizational performance improvement. It operates in the business segments of North America, International Direct Offices, International Licensees, Education Division. The company derives revenue from providing training and consulting services and through the sale of books, audio media, and other related products. It has a business presence in Australia, New Zealand, China, Japan, the United Kingdom, Ireland, and Other countries.